- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Duchenne Muscular Dystrophy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Duchenne Muscular Dystrophy market size is estimated to be worth US$ 1237.8 million in 2021 and is forecast to a readjusted size of USD 13240 million by 2028 with a CAGR of 40.3% during review period. Hospitals accounting for % of the Duchenne Muscular Dystrophy global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Exondys 51 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Duchenne Muscular Dystrophy include Sarepta Therapeutics, PTC Therapeutics, Pfizer, Bristol-Myers Squibb, and Italfarmaco, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Duchenne Muscular Dystrophy market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Exondys 51
Emflaza
Translarna
Market segment by Application can be divided into
Hospitals
Clinics
Home Care
The key market players for global Duchenne Muscular Dystrophy market are listed below:
Sarepta Therapeutics
PTC Therapeutics
Pfizer
Bristol-Myers Squibb
Italfarmaco
Santhera Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Duchenne Muscular Dystrophy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Duchenne Muscular Dystrophy, with price, sales, revenue and global market share of Duchenne Muscular Dystrophy from 2019 to 2022.
Chapter 3, the Duchenne Muscular Dystrophy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Duchenne Muscular Dystrophy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Duchenne Muscular Dystrophy market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Duchenne Muscular Dystrophy.
Chapter 13, 14, and 15, to describe Duchenne Muscular Dystrophy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Duchenne Muscular Dystrophy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Duchenne Muscular Dystrophy Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Exondys 51
1.2.3 Emflaza
1.2.4 Translarna
1.3 Market Analysis by Application
1.3.1 Overview: Global Duchenne Muscular Dystrophy Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Global Duchenne Muscular Dystrophy Market Size & Forecast
1.4.1 Global Duchenne Muscular Dystrophy Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Duchenne Muscular Dystrophy Sales in Volume (2017-2028)
1.4.3 Global Duchenne Muscular Dystrophy Price (2017-2028)
1.5 Global Duchenne Muscular Dystrophy Production Capacity Analysis
1.5.1 Global Duchenne Muscular Dystrophy Total Production Capacity (2017-2028)
1.5.2 Global Duchenne Muscular Dystrophy Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Duchenne Muscular Dystrophy Market Drivers
1.6.2 Duchenne Muscular Dystrophy Market Restraints
1.6.3 Duchenne Muscular Dystrophy Trends Analysis
2 Manufacturers Profiles
2.1 Sarepta Therapeutics
2.1.1 Sarepta Therapeutics Details
2.1.2 Sarepta Therapeutics Major Business
2.1.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Product and Services
2.1.4 Sarepta Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 PTC Therapeutics
2.2.1 PTC Therapeutics Details
2.2.2 PTC Therapeutics Major Business
2.2.3 PTC Therapeutics Duchenne Muscular Dystrophy Product and Services
2.2.4 PTC Therapeutics Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Duchenne Muscular Dystrophy Product and Services
2.3.4 Pfizer Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Duchenne Muscular Dystrophy Product and Services
2.4.4 Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Italfarmaco
2.5.1 Italfarmaco Details
2.5.2 Italfarmaco Major Business
2.5.3 Italfarmaco Duchenne Muscular Dystrophy Product and Services
2.5.4 Italfarmaco Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Santhera Pharmaceuticals
2.6.1 Santhera Pharmaceuticals Details
2.6.2 Santhera Pharmaceuticals Major Business
2.6.3 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product and Services
2.6.4 Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Duchenne Muscular Dystrophy Breakdown Data by Manufacturer
3.1 Global Duchenne Muscular Dystrophy Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Duchenne Muscular Dystrophy Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Duchenne Muscular Dystrophy
3.4 Market Concentration Rate
3.4.1 Top 3 Duchenne Muscular Dystrophy Manufacturer Market Share in 2021
3.4.2 Top 6 Duchenne Muscular Dystrophy Manufacturer Market Share in 2021
3.5 Global Duchenne Muscular Dystrophy Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Duchenne Muscular Dystrophy Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Duchenne Muscular Dystrophy Market Size by Region
4.1.1 Global Duchenne Muscular Dystrophy Sales in Volume by Region (2017-2028)
4.1.2 Global Duchenne Muscular Dystrophy Revenue by Region (2017-2028)
4.2 North America Duchenne Muscular Dystrophy Revenue (2017-2028)
4.3 Europe Duchenne Muscular Dystrophy Revenue (2017-2028)
4.4 Asia-Pacific Duchenne Muscular Dystrophy Revenue (2017-2028)
4.5 South America Duchenne Muscular Dystrophy Revenue (2017-2028)
4.6 Middle East and Africa Duchenne Muscular Dystrophy Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Duchenne Muscular Dystrophy Sales in Volume by Type (2017-2028)
5.2 Global Duchenne Muscular Dystrophy Revenue by Type (2017-2028)
5.3 Global Duchenne Muscular Dystrophy Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Duchenne Muscular Dystrophy Sales in Volume by Application (2017-2028)
6.2 Global Duchenne Muscular Dystrophy Revenue by Application (2017-2028)
6.3 Global Duchenne Muscular Dystrophy Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Duchenne Muscular Dystrophy Sales by Type (2017-2028)
7.2 North America Duchenne Muscular Dystrophy Sales by Application (2017-2028)
7.3 North America Duchenne Muscular Dystrophy Market Size by Country
7.3.1 North America Duchenne Muscular Dystrophy Sales in Volume by Country (2017-2028)
7.3.2 North America Duchenne Muscular Dystrophy Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Duchenne Muscular Dystrophy Sales by Type (2017-2028)
8.2 Europe Duchenne Muscular Dystrophy Sales by Application (2017-2028)
8.3 Europe Duchenne Muscular Dystrophy Market Size by Country
8.3.1 Europe Duchenne Muscular Dystrophy Sales in Volume by Country (2017-2028)
8.3.2 Europe Duchenne Muscular Dystrophy Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Duchenne Muscular Dystrophy Sales by Type (2017-2028)
9.2 Asia-Pacific Duchenne Muscular Dystrophy Sales by Application (2017-2028)
9.3 Asia-Pacific Duchenne Muscular Dystrophy Market Size by Region
9.3.1 Asia-Pacific Duchenne Muscular Dystrophy Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Duchenne Muscular Dystrophy Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Duchenne Muscular Dystrophy Sales by Type (2017-2028)
10.2 South America Duchenne Muscular Dystrophy Sales by Application (2017-2028)
10.3 South America Duchenne Muscular Dystrophy Market Size by Country
10.3.1 South America Duchenne Muscular Dystrophy Sales in Volume by Country (2017-2028)
10.3.2 South America Duchenne Muscular Dystrophy Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Duchenne Muscular Dystrophy Sales by Type (2017-2028)
11.2 Middle East & Africa Duchenne Muscular Dystrophy Sales by Application (2017-2028)
11.3 Middle East & Africa Duchenne Muscular Dystrophy Market Size by Country
11.3.1 Middle East & Africa Duchenne Muscular Dystrophy Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Duchenne Muscular Dystrophy Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Duchenne Muscular Dystrophy and Key Manufacturers
12.2 Manufacturing Costs Percentage of Duchenne Muscular Dystrophy
12.3 Duchenne Muscular Dystrophy Production Process
12.4 Duchenne Muscular Dystrophy Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Duchenne Muscular Dystrophy Typical Distributors
13.3 Duchenne Muscular Dystrophy Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Duchenne Muscular Dystrophy Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Duchenne Muscular Dystrophy Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Sarepta Therapeutics Major Business
Table 5. Sarepta Therapeutics Duchenne Muscular Dystrophy Product and Services
Table 6. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. PTC Therapeutics Basic Information, Manufacturing Base and Competitors
Table 8. PTC Therapeutics Major Business
Table 9. PTC Therapeutics Duchenne Muscular Dystrophy Product and Services
Table 10. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Duchenne Muscular Dystrophy Product and Services
Table 14. Pfizer Duchenne Muscular Dystrophy Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 16. Bristol-Myers Squibb Major Business
Table 17. Bristol-Myers Squibb Duchenne Muscular Dystrophy Product and Services
Table 18. Bristol-Myers Squibb Duchenne Muscular Dystrophy Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Italfarmaco Basic Information, Manufacturing Base and Competitors
Table 20. Italfarmaco Major Business
Table 21. Italfarmaco Duchenne Muscular Dystrophy Product and Services
Table 22. Italfarmaco Duchenne Muscular Dystrophy Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Santhera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Santhera Pharmaceuticals Major Business
Table 25. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Product and Services
Table 26. Santhera Pharmaceuticals Duchenne Muscular Dystrophy Sales (K Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Duchenne Muscular Dystrophy Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Doses)
Table 28. Global Duchenne Muscular Dystrophy Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Duchenne Muscular Dystrophy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Duchenne Muscular Dystrophy Production Capacity by Company, (K Doses): 2020 VS 2021
Table 31. Head Office and Duchenne Muscular Dystrophy Production Site of Key Manufacturer
Table 32. Duchenne Muscular Dystrophy New Entrant and Capacity Expansion Plans
Table 33. Duchenne Muscular Dystrophy Mergers & Acquisitions in the Past Five Years
Table 34. Global Duchenne Muscular Dystrophy Sales by Region (2017-2022) & (K Doses)
Table 35. Global Duchenne Muscular Dystrophy Sales by Region (2023-2028) & (K Doses)
Table 36. Global Duchenne Muscular Dystrophy Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Duchenne Muscular Dystrophy Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Duchenne Muscular Dystrophy Sales by Type (2017-2022) & (K Doses)
Table 39. Global Duchenne Muscular Dystrophy Sales by Type (2023-2028) & (K Doses)
Table 40. Global Duchenne Muscular Dystrophy Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Duchenne Muscular Dystrophy Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Duchenne Muscular Dystrophy Price by Type (2017-2022) & (USD/Dose)
Table 43. Global Duchenne Muscular Dystrophy Price by Type (2023-2028) & (USD/Dose)
Table 44. Global Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Doses)
Table 45. Global Duchenne Muscular Dystrophy Sales by Application (2023-2028) & (K Doses)
Table 46. Global Duchenne Muscular Dystrophy Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Duchenne Muscular Dystrophy Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Duchenne Muscular Dystrophy Price by Application (2017-2022) & (USD/Dose)
Table 49. Global Duchenne Muscular Dystrophy Price by Application (2023-2028) & (USD/Dose)
Table 50. North America Duchenne Muscular Dystrophy Sales by Country (2017-2022) & (K Doses)
Table 51. North America Duchenne Muscular Dystrophy Sales by Country (2023-2028) & (K Doses)
Table 52. North America Duchenne Muscular Dystrophy Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Duchenne Muscular Dystrophy Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Duchenne Muscular Dystrophy Sales by Type (2017-2022) & (K Doses)
Table 55. North America Duchenne Muscular Dystrophy Sales by Type (2023-2028) & (K Doses)
Table 56. North America Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Doses)
Table 57. North America Duchenne Muscular Dystrophy Sales by Application (2023-2028) & (K Doses)
Table 58. Europe Duchenne Muscular Dystrophy Sales by Country (2017-2022) & (K Doses)
Table 59. Europe Duchenne Muscular Dystrophy Sales by Country (2023-2028) & (K Doses)
Table 60. Europe Duchenne Muscular Dystrophy Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Duchenne Muscular Dystrophy Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Duchenne Muscular Dystrophy Sales by Type (2017-2022) & (K Doses)
Table 63. Europe Duchenne Muscular Dystrophy Sales by Type (2023-2028) & (K Doses)
Table 64. Europe Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Doses)
Table 65. Europe Duchenne Muscular Dystrophy Sales by Application (2023-2028) & (K Doses)
Table 66. Asia-Pacific Duchenne Muscular Dystrophy Sales by Region (2017-2022) & (K Doses)
Table 67. Asia-Pacific Duchenne Muscular Dystrophy Sales by Region (2023-2028) & (K Doses)
Table 68. Asia-Pacific Duchenne Muscular Dystrophy Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Duchenne Muscular Dystrophy Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Duchenne Muscular Dystrophy Sales by Type (2017-2022) & (K Doses)
Table 71. Asia-Pacific Duchenne Muscular Dystrophy Sales by Type (2023-2028) & (K Doses)
Table 72. Asia-Pacific Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Doses)
Table 73. Asia-Pacific Duchenne Muscular Dystrophy Sales by Application (2023-2028) & (K Doses)
Table 74. South America Duchenne Muscular Dystrophy Sales by Country (2017-2022) & (K Doses)
Table 75. South America Duchenne Muscular Dystrophy Sales by Country (2023-2028) & (K Doses)
Table 76. South America Duchenne Muscular Dystrophy Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Duchenne Muscular Dystrophy Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Duchenne Muscular Dystrophy Sales by Type (2017-2022) & (K Doses)
Table 79. South America Duchenne Muscular Dystrophy Sales by Type (2023-2028) & (K Doses)
Table 80. South America Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Doses)
Table 81. South America Duchenne Muscular Dystrophy Sales by Application (2023-2028) & (K Doses)
Table 82. Middle East & Africa Duchenne Muscular Dystrophy Sales by Region (2017-2022) & (K Doses)
Table 83. Middle East & Africa Duchenne Muscular Dystrophy Sales by Region (2023-2028) & (K Doses)
Table 84. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Duchenne Muscular Dystrophy Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Duchenne Muscular Dystrophy Sales by Type (2017-2022) & (K Doses)
Table 87. Middle East & Africa Duchenne Muscular Dystrophy Sales by Type (2023-2028) & (K Doses)
Table 88. Middle East & Africa Duchenne Muscular Dystrophy Sales by Application (2017-2022) & (K Doses)
Table 89. Middle East & Africa Duchenne Muscular Dystrophy Sales by Application (2023-2028) & (K Doses)
Table 90. Duchenne Muscular Dystrophy Raw Material
Table 91. Key Manufacturers of Duchenne Muscular Dystrophy Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Duchenne Muscular Dystrophy Typical Distributors
Table 95. Duchenne Muscular Dystrophy Typical Customers
List of Figures
Figure 1. Duchenne Muscular Dystrophy Picture
Figure 2. Global Duchenne Muscular Dystrophy Revenue Market Share by Type in 2021
Figure 3. Exondys 51
Figure 4. Emflaza
Figure 5. Translarna
Figure 6. Global Duchenne Muscular Dystrophy Revenue Market Share by Application in 2021
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Home Care
Figure 10. Global Duchenne Muscular Dystrophy Revenue, (USD Million) & (K Doses): 2017 & 2021 & 2028
Figure 11. Global Duchenne Muscular Dystrophy Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Duchenne Muscular Dystrophy Sales (2017-2028) & (K Doses)
Figure 13. Global Duchenne Muscular Dystrophy Price (2017-2028) & (USD/Dose)
Figure 14. Global Duchenne Muscular Dystrophy Production Capacity (2017-2028) & (K Doses)
Figure 15. Global Duchenne Muscular Dystrophy Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Duchenne Muscular Dystrophy Market Drivers
Figure 17. Duchenne Muscular Dystrophy Market Restraints
Figure 18. Duchenne Muscular Dystrophy Market Trends
Figure 19. Global Duchenne Muscular Dystrophy Sales Market Share by Manufacturer in 2021
Figure 20. Global Duchenne Muscular Dystrophy Revenue Market Share by Manufacturer in 2021
Figure 21. Duchenne Muscular Dystrophy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Duchenne Muscular Dystrophy Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Duchenne Muscular Dystrophy Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Duchenne Muscular Dystrophy Sales Market Share by Region (2017-2028)
Figure 25. Global Duchenne Muscular Dystrophy Revenue Market Share by Region (2017-2028)
Figure 26. North America Duchenne Muscular Dystrophy Revenue (2017-2028) & (USD Million)
Figure 27. Europe Duchenne Muscular Dystrophy Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Duchenne Muscular Dystrophy Revenue (2017-2028) & (USD Million)
Figure 29. South America Duchenne Muscular Dystrophy Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Duchenne Muscular Dystrophy Revenue (2017-2028) & (USD Million)
Figure 31. Global Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2028)
Figure 32. Global Duchenne Muscular Dystrophy Revenue Market Share by Type (2017-2028)
Figure 33. Global Duchenne Muscular Dystrophy Price by Type (2017-2028) & (USD/Dose)
Figure 34. Global Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2028)
Figure 35. Global Duchenne Muscular Dystrophy Revenue Market Share by Application (2017-2028)
Figure 36. Global Duchenne Muscular Dystrophy Price by Application (2017-2028) & (USD/Dose)
Figure 37. North America Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2028)
Figure 38. North America Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2028)
Figure 39. North America Duchenne Muscular Dystrophy Sales Market Share by Country (2017-2028)
Figure 40. North America Duchenne Muscular Dystrophy Revenue Market Share by Country (2017-2028)
Figure 41. United States Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2028)
Figure 45. Europe Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2028)
Figure 46. Europe Duchenne Muscular Dystrophy Sales Market Share by Country (2017-2028)
Figure 47. Europe Duchenne Muscular Dystrophy Revenue Market Share by Country (2017-2028)
Figure 48. Germany Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Duchenne Muscular Dystrophy Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Duchenne Muscular Dystrophy Revenue Market Share by Region (2017-2028)
Figure 57. China Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2028)
Figure 64. South America Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2028)
Figure 65. South America Duchenne Muscular Dystrophy Sales Market Share by Country (2017-2028)
Figure 66. South America Duchenne Muscular Dystrophy Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Duchenne Muscular Dystrophy Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Duchenne Muscular Dystrophy Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Duchenne Muscular Dystrophy Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Duchenne Muscular Dystrophy in 2021
Figure 78. Manufacturing Process Analysis of Duchenne Muscular Dystrophy
Figure 79. Duchenne Muscular Dystrophy Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
